6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
4m ago	UPDATED NOTICE REGARDING THE PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS
4m ago	London's Top Restaurants Named at Inaugural OpenTable Awards, Including New 'Icons'
5m ago	eDreams ODIGEO Exceeds Subscriber Growth Target by 5% and Reaches 7.9 Million Prime Members
29m ago	Smithfield Foods Reports Record First Quarter Fiscal 2026 Results
29m ago	ETC’s Aerospace and Commercial/Industrial Units Awarded Contracts of Approximately $37 Million

About

Cellectar Biosciences Inc (NASDAQ:CLRB) — investor relations, events, news, and company updates on 6ix.

Latest News

Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)

Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026

Cellectar Biosciences Expands Global Intellectual Property Estate

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

Financials

Revenue

$0

Market Cap

$10.81 M

EPS

-8.35

Community Chat

Ask AI